Study of AK112 in the Treatment of Advanced Gynecological Tumors
NCT04870177
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
53
Enrollment
INDUSTRY
Sponsor class
Conditions
Gynecologic Cancer
Cancer Metastatic
Ovarian Neoplasms
Cervical Neoplasm
Endometrial Neoplasms
Interventions
DRUG:
AK112
Sponsor
Akeso